To better characterize the subpopulations that expressed CD28 and CD226 either alone or together, CD8+ tumor-infiltrating lymphocytes (TILs) were gated to assess the phenotypic markers associated with all possible combinations of CD226 and CD28 expression. The gene discussed is CD28; the disease is neoplasm.